Cardinal Health has agreed to acquire a majority stake in GI Alliance, a gastroenterology management services organization, and Advanced Diabetes Supply Group for a combined total of $3.9 billion, ...

Dr. Ma currently serves as Executive Vice President, Pharmaceutical Development and Manufacturing at Gilead Sciences, Inc., ...

In a new policy brief, scientists from the Complexity Science Hub and other international research institutions highlight the urgent need for the G20 to lead efforts in collecting comprehensive supply ...

Watch out, Gilead and Novartis ... As any cell therapy maker knows, initial supply can make or break a CAR-T roll out and has hindered others in the past. Autolus is confident in its supply chain ...

MARKHAM — ventureLAB, a global founder community for hardware technology and enterprise software companies in Canada, and Hudson Valley FastFab Inc. (HVFF), a company promoting advanced solutions in ...

Global Regenerative Medicine Market is valued at approximately USD 34.56 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 32.4% over the forecast period 2024-2032.

(Nasdaq: GILD) announced today its third quarter 2024 results of operations. "Gilead’s third quarter results are the strongest of the year to date, with 7% year-over-year revenue growth, including 13% ...

Hudson holds 35% of the refrigerant reclamation market, benefiting from the AIM Act's phase down of virgin HFC production.

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) yesterday and set a price target ...

Investors in Gilead ... for Gilead Sciences Inc, and highlighting in green where the $88.00 strike is located relative to that history: Turning to the calls side of the option chain, the call ...